Seqirus Pty Ltd
Regulatory activities for this sponsor.
Loading...
- ARTG (88)
- Cancellation by sponsor (27)
- Prescription medicine registration (14)
- Australian Public Assessment Report (AusPAR) (11)
- Prescription medicine evaluation (5)
- Section 14, TGO91 consent (3)
- Prescription medicine decision summary (2)
- Cancellation or suspension (1)
- Designation or determination (1)
Sponsor content
152 result(s) found, displaying 11 to 20
-
Prescription medicine decision summaryOnakta (tirbanibulin) is indicated for the topical field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis of the face or scalp in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUAD QUAD prefilled syringe(Influenza Surface Antigen,MF59C.1 adjuvanted vaccine).
-
Australian Public Assessment Report (AusPAR)Flucelvax Quad (Influenza virus haemagglutinin), a vaccine for the prevention of influenza caused by Influenza Virus Types A and B , has been approved.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAVNEOS avacopan 10 mg hard capsule bottle.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KORSUVA difelikefalin (as acetate) 50 microgram/1 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAZKEPA icosapent ethyl 998 mg soft capsule blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VAZKEPA icosapent ethyl 998 mg soft capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Panvax H5N1 Influenza Vaccine.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.